Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
2009-3-11
pubmed:abstractText
Patients with sepsis have a marked defect in neutrophil migration. Here we identify a key role of Toll-like receptor 2 (TLR2) in the regulation of neutrophil migration and resistance during polymicrobial sepsis. We found that the expression of the chemokine receptor CXCR2 was dramatically down-regulated in circulating neutrophils from WT mice with severe sepsis, which correlates with reduced chemotaxis to CXCL2 in vitro and impaired migration into an infectious focus in vivo. TLR2 deficiency prevented the down-regulation of CXCR2 and failure of neutrophil migration. Moreover, TLR2(-/-) mice exhibited higher bacterial clearance, lower serum inflammatory cytokines, and improved survival rate during severe sepsis compared with WT mice. In vitro, the TLR2 agonist lipoteichoic acid (LTA) down-regulated CXCR2 expression and markedly inhibited the neutrophil chemotaxis and actin polymerization induced by CXCL2. Moreover, neutrophils activated ex vivo by LTA and adoptively transferred into naïve WT recipient mice displayed a significantly reduced competence to migrate toward thioglycolate-induced peritonitis. Finally, LTA enhanced the expression of G protein-coupled receptor kinases 2 (GRK2) in neutrophils; increased expression of GRK2 was seen in blood neutrophils from WT mice, but not TLR2(-/-) mice, with severe sepsis. Our findings identify an unexpected detrimental role of TLR2 in polymicrobial sepsis and suggest that inhibition of TLR2 signaling may improve survival from sepsis.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19234125-10085131, http://linkedlifedata.com/resource/pubmed/commentcorrection/19234125-10508278, http://linkedlifedata.com/resource/pubmed/commentcorrection/19234125-10882600, http://linkedlifedata.com/resource/pubmed/commentcorrection/19234125-11067888, http://linkedlifedata.com/resource/pubmed/commentcorrection/19234125-11792151, http://linkedlifedata.com/resource/pubmed/commentcorrection/19234125-12006803, http://linkedlifedata.com/resource/pubmed/commentcorrection/19234125-12069927, http://linkedlifedata.com/resource/pubmed/commentcorrection/19234125-12086974, http://linkedlifedata.com/resource/pubmed/commentcorrection/19234125-12239185, http://linkedlifedata.com/resource/pubmed/commentcorrection/19234125-12592402, http://linkedlifedata.com/resource/pubmed/commentcorrection/19234125-12960399, http://linkedlifedata.com/resource/pubmed/commentcorrection/19234125-14620132, http://linkedlifedata.com/resource/pubmed/commentcorrection/19234125-14991094, http://linkedlifedata.com/resource/pubmed/commentcorrection/19234125-15229469, http://linkedlifedata.com/resource/pubmed/commentcorrection/19234125-15894165, http://linkedlifedata.com/resource/pubmed/commentcorrection/19234125-16424729, http://linkedlifedata.com/resource/pubmed/commentcorrection/19234125-16498448, http://linkedlifedata.com/resource/pubmed/commentcorrection/19234125-16829300, http://linkedlifedata.com/resource/pubmed/commentcorrection/19234125-16849637, http://linkedlifedata.com/resource/pubmed/commentcorrection/19234125-17138957, http://linkedlifedata.com/resource/pubmed/commentcorrection/19234125-17643110, http://linkedlifedata.com/resource/pubmed/commentcorrection/19234125-17717539, http://linkedlifedata.com/resource/pubmed/commentcorrection/19234125-18180038, http://linkedlifedata.com/resource/pubmed/commentcorrection/19234125-18474631, http://linkedlifedata.com/resource/pubmed/commentcorrection/19234125-18704017, http://linkedlifedata.com/resource/pubmed/commentcorrection/19234125-6997619, http://linkedlifedata.com/resource/pubmed/commentcorrection/19234125-7836371, http://linkedlifedata.com/resource/pubmed/commentcorrection/19234125-9501202, http://linkedlifedata.com/resource/pubmed/commentcorrection/19234125-9759500
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1091-6490
pubmed:author
pubmed:issnType
Electronic
pubmed:day
10
pubmed:volume
106
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
4018-23
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
Regulation of chemokine receptor by Toll-like receptor 2 is critical to neutrophil migration and resistance to polymicrobial sepsis.
pubmed:affiliation
Department of Pharmacology, School of Medicine of Ribeirão Preto, University of Säo Paulo, 14049-900 Ribeirão Preto, Brazil. jcafilho@usp.br
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't